Tickerover
Healthcare

SHC Stock Analysis

Sotera Health Company · current price $19.27 (-1.00% today)

Top-tier setup — 4/4 EPS beats. Momentum, fundamentals and macro indicators are aligned.
★★★★★
Top Tier
📊

The six-pillar scorecard

Momentum
74
Trending up strong
price trend
Growth
28
Barely growing
sales & profit growth
Quality
64
Solid fundamentals
profitability & balance sheet
Valuation
65
Fairly priced
is the price fair?
Sentiment
47
Mixed views
analyst & crowd mood
Risk
60
Moderate risk
volatility & drawdown

Each pillar is scored 0-100 inside the stock’s own peer group, so a chipmaker is measured against chipmakers. These are quality descriptors, not buy or sell signals.

📉

The picture

What drove the scoreThe seven components contributing most, each read out of 100.
GrowthGrowth: 7878Relative strengthRelative strength: 100100RSI zoneRSI zone: 100100Trend strengthTrend strength: 1001001-month momentum1-month momentum: 6262Breakout proximityBreakout proximity: 7171Analyst consensusAnalyst consensus: 7070
Margin profileWhat survives each step down the income statement.
GrossGross: 55.0%55.0%OperatingOperating: 38.0%38.0%NetNet: 13.4%13.4%Free cash flowFree cash flow: 9.3%9.3%
EPS surpriseReported EPS against estimate, last four quarters.
2026-06: +8.7% vs estimate+9%2026-062026-03: +3.4% vs estimate+3%2026-032025-12: +7.0% vs estimate+7%2025-122025-09: +19.1% vs estimate+19%2025-09
👁

Hype Check

Reading SHC’s price and volume history…

The audit — what has to hold for this thesis

Checking the areas that decide this thesis…

AI-generated from the company’s own filings and recent coverage, and it can be incomplete or wrong. A PASS is a reading of the cited evidence, not a verified fact and not a reason to buy. Follow each citation to the source.

🛡

Dilution Check

Reading SHC’s filings…

📣

Latest earnings

LAST EARNINGS Sotera Health Company (SHC)

Latest earnings

EPS
$0.26 vs $0.22 est · +19.1% vs estimate BEAT
Revenue
$321.4M · +3.2% YoY
Stock reaction (1M)
+8.0%
Beat streak
4 of last 4 quarters
💰

Valuation

P/E
34.4×
Forward P/E
17.9×
PEG
1.31
Price / Sales
4.5×
Price / Book
8.3×
EV / EBITDA
12.9×
Analyst target
$22.72
Target range
$18.00 – $25.00
Implied upside
+17.9%
🩺

Financial health

Gross margin
55.0%
Operating margin
38.0%
Net margin
13.4%
FCF margin
9.3%
Return on equity
27.8%
Debt / equity
3.41
Revenue growth YoY
+9.2%
EPS growth YoY
+5.7%
📈

Technicals

$13.0952-week range$19.85
RSI (14)
59
50-day MA
$18.08
200-day MA
$16.74
ATR (14)
0.42
Beta
1.77
1-month return
+8.0%
🗓️

Earnings

QuarterEPSEst.SurpriseResult
2025-09-30$0.26$0.22+19.1%Beat
2025-12-31$0.26$0.24+7.0%Beat
2026-03-31$0.18$0.17+3.4%Beat
2026-06-30$0.26$0.24+8.7%Beat
Beat 4 of the last 4 quarters.
🏛️

Ownership & risk

Short % of float
0.05%
Beta
1.77
🔗

Similar stocks in Healthcare

Frequently asked

What is SHC's Quant Score?

Sotera Health Company (SHC) currently has a TickerMover Quant Score of 78/100, rated ★★★★★ Top Tier. The Quant Score is a quantitative composite across six research pillars — momentum, quality, growth, valuation, sentiment and risk. It is research information, not investment advice.

Is Sotera Health Company (SHC) a buy?

TickerMover does not give buy or sell recommendations. SHC scores 78/100 (★★★★★ Top Tier) on our quantitative research model — a screening signal, not a personal recommendation. Do your own research, and consider an FCA-authorised adviser before investing.

How often is SHC's score updated?

SHC's Quant Score and underlying data refresh through US market hours (about every five minutes), using public market and fundamental data.

Get the full live dashboard

Real-time scoring, conflict detection, Reverse DCF and peer comparison — free while in beta.

Open the dashboard for SHC →